IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials
Go back to IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials| (NYSE: IQV) | Delayed: 260.72 -8.13 (3.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $268.85 | 52 Week High | $ | |||
| Open | $268.02 | 52 Week Low | $ | |||
| Day High | $268.88 | P/E | N/A | |||
| Day Low | $259.31 | EPS | $ | |||
| Volume | 1,476,476 | |||||

